By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Abeona Therapeutics 



Cleveland  Ohio    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Abeona Therapeutics To Host Gene Therapy R&D Day On October 11, 2017 8/17/2017 8:57:53 AM
Abeona Therapeutics Announces Pivotal Expansion Of ABO-102 Gene Therapy Clinical Trials In Sanfilippo Syndrome Type A 8/16/2017 10:42:31 AM
Abeona Therapeutics Reports Second Quarter 2017 Financial Results And Recent Business Highlights 8/15/2017 7:10:51 AM
Abeona Therapeutics Announces Appointment Of Juan Ruiz As Chief Medical Officer 7/25/2017 11:06:53 AM
Abeona Therapeutics Receives Guidance From FDA To Commence Pivotal Phase III For EB-101 Gene Therapy For Patients With Epidermolysis Bullosa 7/18/2017 10:28:01 AM
Abeona Therapeutics Receives FDA Orphan Drug Designation For ABO-201 Juvenile Batten Disease Gene Therapy Program 6/29/2017 8:27:40 AM
Abeona Therapeutics Receives Rare Pediatric Disease Designation For EB-101 Gene Therapy Product For Patients With Epidermolysis Bullosa 5/30/2017 8:20:20 AM
Abeona Therapeutics Receives FDA Orphan Drug Designation For EB-101 Gene Therapy Product For Patients With Epidermolysis Bullosa 5/25/2017 7:32:46 AM
Abeona Therapeutics Reports First Quarter 2017 Financial Results And Recent Business Highlights 5/16/2017 8:31:33 AM
Abeona Therapeutics Announces Top-Line Data For ABO-102 Phase I/II MPS IIIA Gene Therapy Trial At ASGCT 5/12/2017 7:53:25 AM
123
//-->